Actively Recruiting
Revolade Tablets Specified Drug-use Survey
Led by Novartis Pharmaceuticals · Updated on 2026-02-19
10
Participants Needed
17
Research Sites
223 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a multicenter, single-arm, non-interventional study (NIS) to confirm the safety and efficacy of eltrombopag in Anti-Thymocyte Globulin (ATG) treatment naive pediatric patients with aplastic anemia (AA).
CONDITIONS
Official Title
Revolade Tablets Specified Drug-use Survey
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient's legal guardian has provided written consent to participate in this survey
- Patients aged 6 years and older but younger than 18 years at the start of eltrombopag treatment
- Pediatric patients with aplastic anemia receiving eltrombopag for the first time combined with ATG after approval for this use
You will not qualify if you...
- Patients who have received ATG treatment without using eltrombopag
- Patients diagnosed with congenital aplastic anemia
- Patients suspected or confirmed to have myelodysplastic syndrome at the start of eltrombopag treatment
- Patients who have previously received any drug containing eltrombopag (including experimental treatments)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 17 locations
1
Novartis Investigative Site
Nagoya, Aichi-ken, Japan, 453-8511
Actively Recruiting
2
Novartis Investigative Site
Nagoya, Aichi-ken, Japan, 4668560
Actively Recruiting
3
Novartis Investigative Site
Toyoake, Aichi-ken, Japan, 4701192
Actively Recruiting
4
Novartis Investigative Site
Chiba, Chiba, Japan, 260 8677
Actively Recruiting
5
Novartis Investigative Site
Amagasaki, Hyōgo, Japan, 660 8550
Actively Recruiting
6
Novartis Investigative Site
Kobe, Hyōgo, Japan, 6500047
Actively Recruiting
7
Novartis Investigative Site
Matsumoto, Nagano, Japan, 3908621
Actively Recruiting
8
Novartis Investigative Site
Shimajiri-Gun, Okinawa, Japan, 901-1303
Actively Recruiting
9
Novartis Investigative Site
Izumi, Osaka, Japan, 5941101
Actively Recruiting
10
Novartis Investigative Site
Osaka, Osaka, Japan, 5340021
Actively Recruiting
11
Novartis Investigative Site
Sakai, Osaka, Japan, 590-0197
Actively Recruiting
12
Novartis Investigative Site
Saitama, Saitama, Japan, 3308777
Actively Recruiting
13
Novartis Investigative Site
Ohtsu, Shiga, Japan, 5202192
Actively Recruiting
14
Novartis Investigative Site
Chuo Ku, Tokyo, Japan, 1048560
Actively Recruiting
15
Novartis Investigative Site
Ōta-ku, Tokyo, Japan, 143 8541
Actively Recruiting
16
Novartis Investigative Site
Setagaya-ku, Tokyo, Japan, 1578535
Actively Recruiting
17
Novartis Investigative Site
Wakayama, Wakayama, Japan, 641-8510
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here